Literature DB >> 7748344

Observations of novel behaviors as indices of ethanol withdrawal-induced anxiety.

D J Knapp1, J A Saiers, L A Pohorecky.   

Abstract

One of the prominent symptoms in alcoholics during withdrawal is an intense feeling of anxiety. Recently new tests have become available which may index anxiety in rodents. We have evaluated two such tests in our model of withdrawal from ethanol (ET) in rats. Rats were given either ET in milk (7-13 g/kg/4 days) or equicaloric dextrin maltose in milk via implanted gastric cannuli. Rats were scored for classical withdrawal symptoms (tremors, convulsions, stereotyped behavior), for stimulus-elicited ultrasonic vocalizations (USVs), and in one study for exploration of novel objects placed in their home cage at various points after the last dose of ET. In Sprague-Dawley rats, classical withdrawal symptoms were highest between 8-12 hours, and disappeared by 36 hours. Latency to explore a novel object was unchanged, but duration was depressed between 10-30 hours, and was recovered by 70 hours. Following a less intense Day 1 treatment regimen in Long-Evans rats, the vocalizations were greatly increased in number, and peak response occurred sooner (6 hours post-infusion) and was of shorter overall duration (50 hours). Pretreatment with diazepam (1.25-5.0 mg/kg) depressed the number of vocalizations during ET withdrawal (ETW), which suggests that this measure could index anxiety in animal models of withdrawal from ET.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7748344

Source DB:  PubMed          Journal:  Alcohol Alcohol Suppl        ISSN: 1358-6173


  9 in total

1.  Predictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation.

Authors:  Jon R Fee; Dennis R Sparta; Darin J Knapp; George R Breese; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2004-10       Impact factor: 3.455

2.  Binge alcohol drinking elicits persistent negative affect in mice.

Authors:  Kaziya M Lee; Michal Coehlo; Hadley A McGregor; Ryan S Waltermire; Karen K Szumlinski
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

3.  Complex interactions between the subject factors of biological sex and prior histories of binge-drinking and unpredictable stress influence behavioral sensitivity to alcohol and alcohol intake.

Authors:  Sema G Quadir; Eugenie Guzelian; Mason A Palmer; Douglas L Martin; Jennifer Kim; Karen K Szumlinski
Journal:  Physiol Behav       Date:  2017-08-10

4.  Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor.

Authors:  Montserrat Navarro; Inmaculada Cubero; Airu S Chen; Howard Y Chen; Darin J Knapp; George R Breese; Donald J Marsh; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2005-06       Impact factor: 3.455

5.  Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures.

Authors:  Dennis R Sparta; Angela M Sparrow; Emily G Lowery; Jon R Fee; Darin J Knapp; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

6.  Distinct cell proliferation events during abstinence after alcohol dependence: microglia proliferation precedes neurogenesis.

Authors:  K Nixon; D H Kim; E N Potts; J He; F T Crews
Journal:  Neurobiol Dis       Date:  2008-05-03       Impact factor: 5.996

7.  Peripheral and central administration of a selective neuropeptide Y Y1 receptor antagonist suppresses ethanol intake by C57BL/6J mice.

Authors:  Dennis R Sparta; Jon R Fee; Dayna M Hayes; Darin J Knapp; Douglas J MacNeil; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2004-09       Impact factor: 3.455

8.  Withdrawal from Chronic Alcohol Induces a Unique CCL2 mRNA Increase in Adolescent But Not Adult Brain--Relationship to Blood Alcohol Levels and Seizures.

Authors:  Kathryn M Harper; Darin J Knapp; George R Breese
Journal:  Alcohol Clin Exp Res       Date:  2015-11-11       Impact factor: 3.455

9.  The effectiveness of Bacopa monnieri (Linn.) Wettst. as a nootropic, neuroprotective, or antidepressant supplement: analysis of the available clinical data.

Authors:  James M Brimson; Sirikalaya Brimson; Mani Iyer Prasanth; Premrutai Thitilertdecha; Dicson Sheeja Malar; Tewin Tencomnao
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.